Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 24,500 shares at $7.54 ($184K) on 2017-09-15, disclosed to the SEC on 2017-09-15.
Open-market sale of $184k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.49 | 8,500 | $64K | 34.6% |
| 2 | $7.52 | 6,000 | $45K | 24.5% |
| 3 | $7.54 | 10,000 | $75K | 40.9% |
| Total | $7.52 avg | 24,500 | $184K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |